Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings.
Neily ZakiyahRobin TuyttenPhilip N BakerLouise C KennyMaarten J PostmaAntoinette D I van Asseltnull nullPublished in: PloS one (2022)
The results indicate that the new screening test for preeclampsia has potential to be cost-effective. Further studies based on proven accuracy of the test will confirm whether the new screening test is a cost-effective additional option to the current situation.